GSK Vaccine Manufacturing Plan Alternates Pandemic And Seasonal Flu
This article was originally published in The Pink Sheet Daily
Executive Summary
Results from one of two Phase I pandemic flu vaccine trials in the third quarter will support accelerated European regulatory efforts.